BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fenofibrate
,
rs2230926
,
ERBB2
,
Apoptosis
,
Inflammatory disorder
,
Intestine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MYC protein
Summary
General Info
Curated Studies
Most Correlated Studies
Induced pluripotent stem cells by direct delivery of Oct4, Sox2, Klf4,and c-Myc proteins
Mammary tumors from 8 different mouse models of human breast cancer
Affects of signal pathway activation on genome-wide expression
Mammary tumors from multiple genetic mouse breast cancer models
Induced pluripotent stem cells cultured in small molecule, fate maintenance, or conventional medium
Explore Curated Studies Results
Literature
Most Relevant Literature
Regulation of lipid and serine metabolism by the oncogene c-Myc.
A druggable conformational switch in the c-MYC transactivation domain.
Implications of c-Myc in the pathogenesis and treatment efficacy of urological cancers.
Antitumor Effect of Anti-c-Myc Aptamer-Based PROTAC for Degradation of the c-Myc Protein.
Selective binding of c-MYC G-quadruplex caged in a dsDNA by a hemopeptide.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcript…
DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Re…
SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL W…
Mycoprotein and Muscle Protein Synthetic Response
Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Di…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ